Recent Insider Transactions • May 27
Chairman of the Board recently sold €2.0m worth of stock On the 25th of May, Johan Tigerschiold sold around 70k shares on-market at roughly €28.30 per share. This transaction amounted to 35% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Johan's only on-market trade for the last 12 months. Board Change • May 20
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 3 highly experienced directors. Independent Director Jens Hinrichsen was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Tillkännagivande • Oct 24
Mycronic AB (publ) to Report Fiscal Year 2025 Final Results on Apr 01, 2026 Mycronic AB (publ) announced that they will report fiscal year 2025 final results at 9:00 AM, Central European Standard Time on Apr 01, 2026 Tillkännagivande • Jul 11
Mycronic AB (Publ) Provides Revenue Guidance for 2025 Mycronic AB (publ) provided revenue guidance for 2025. For the period, the company expects to revert to its original opinion regarding net sales for 2025 to be at a level of SEK 7.5 billion, from previously a level of SEK 7.0 to 7.5 billion. Tillkännagivande • Jun 04
Mycronic AB (publ) (OM:MYCR) acquired remaining 92.50% stake in Surfx Technologies LLC. Mycronic AB (publ) (OM:MYCR) acquired remaining 92.50% stake in Surfx Technologies LLC on June 3, 2025. Surfx will form a new business line within the Global Technologies division of Mycronic.
Mycronic AB (publ) (OM:MYCR) completed the acquisition of remaining 92.50% stake in Surfx Technologies LLC on June 3, 2025. Tillkännagivande • May 08
Mycronic AB (Publ) Approves Ordinary Dividend, Payable on May 14, 2025 Mycronic AB (publ) in its Annual General Meeting held on May 7, 2025 resolved in accordance with the Board of Directors' proposal, on a dividend of SEK 5.50 per share in ordinary dividend. The record date for receiving dividend was set to May 9, 2025, and the dividend is expected to be distributed on May 14, 2025. Tillkännagivande • Apr 08
Mycronic AB (publ) (OM:MYCR) acquired RoBAT Ltd. Mycronic AB (publ) (OM:MYCR) acquired RoBAT Ltd. on April 7, 2025.
For the period ending December 31, 2024, RoBAT Ltd. reported total revenue of £3 million.
Mycronic AB (publ) (OM:MYCR) completed the acquisition of RoBAT Ltd. on April 7, 2025. Tillkännagivande • Mar 14
Mycronic AB (publ) (OM:MYCR) acquired Hprobe SA from High-Tech Gründerfonds Management GmbH and others. Mycronic AB (publ) (OM:MYCR) acquired Hprobe SA from High-Tech Gründerfonds Management GmbH and others on March 13, 2025. As an early backer of Hprobe, HTGF, one of Europe’s leading seed investors, led a significant financing round in 2019 and has closely supported the successful development of the startup. As part of the transaction, HTGF has sold its stake. Hprobe is an innovative high-tech company, founded in 2017, with currently 14 employees. Net sales in 2024 amounted to €4 million. Hprobe will form a new business line within the Global Technologies division.
Mycronic AB (publ) (OM:MYCR) completed the acquisition of Hprobe SA from High-Tech Gründerfonds Management GmbH and others on March 13, 2025. Tillkännagivande • Feb 09
Mycronic AB (Publ) Proposes Extra Dividend, Payable on May 14, 2025 The Board of Directors of Mycronic AB (publ) proposed an extra dividend of SEK 2.00 per share. The record date for entitlement to the dividend is proposed as May 9, 2025. Provided the Meeting resolves in favor of the dividend proposal, the dividend will be paid on May 14, 2025. Tillkännagivande • Feb 07
Mycronic AB (publ), Annual General Meeting, May 07, 2025 Mycronic AB (publ), Annual General Meeting, May 07, 2025. Buy Or Sell Opportunity • Oct 29
Now 21% undervalued Over the last 90 days, the stock has risen 14% to €36.82. The fair value is estimated to be €46.64, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 15% over the last 3 years. Earnings per share has grown by 31%. Revenue is forecast to grow by 13% in 2 years. Earnings are forecast to grow by 15% in the next 2 years. Reported Earnings • Oct 24
Third quarter 2024 earnings released: EPS: kr4.59 (vs kr2.10 in 3Q 2023) Third quarter 2024 results: EPS: kr4.59 (up from kr2.10 in 3Q 2023). Revenue: kr1.78b (up 40% from 3Q 2023). Net income: kr448.0m (up 119% from 3Q 2023). Profit margin: 25% (up from 16% in 3Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Oct 24
Mycronic AB (Publ) Reaffirms Sales Guidance for the Year 2024 Mycronic AB (publ) reaffirmed sales guidance for the year 2024. The board of directors' opinion remains that net sales for 2024 will be at a level of SEK 6.5 billion. Tillkännagivande • Oct 17
Mycronic AB (publ) (OM:MYCR) acquired Modus High Tech Electronics GmbH. Mycronic AB (publ) (OM:MYCR) acquired Modus High Tech Electronics GmbH on October 17, 2024.
For the period ending December 31, 2023, Modus High Tech Electronics GmbH reported total revenue of €4 million.
Mycronic AB (publ) (OM:MYCR) completed the acquisition of Modus High Tech Electronics GmbH on October 17, 2024. Tillkännagivande • Sep 13
Mycronic AB (publ) Appoints Nomination Committee Mycronic AB (publ) announced the Nomination Committee for Mycronic's 2025 Annual General Meeting has been appointed in accordance with the instructions for the Nomination Committee as decided by the 2024 Annual General Meeting. The Nomination Committee comprises: Henrik Blomquist, Bure Equity; Patrik Jönsson, SEB Funds; Thomas Ehlin, The Fourth Swedish National Pension Fund; Patrik Tigerschiöld, Chairman. Reported Earnings • Jul 14
Second quarter 2024 earnings released: EPS: kr2.94 (vs kr1.37 in 2Q 2023) Second quarter 2024 results: EPS: kr2.94 (up from kr1.37 in 2Q 2023). Revenue: kr1.53b (up 23% from 2Q 2023). Net income: kr287.0m (up 114% from 2Q 2023). Profit margin: 19% (up from 11% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 8.7% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. Tillkännagivande • May 10
Mycronic AB (publ) to Report Q1, 2025 Results on Apr 25, 2025 Mycronic AB (publ) announced that they will report Q1, 2025 results on Apr 25, 2025 Tillkännagivande • May 09
Mycronic AB (Publ) Approves Dividend, Payable on May 16, 2024 The Annual General Meeting of Mycronic AB (publ) was held on May 8, 2024. The Annual General Meeting resolved, in accordance with the Board of Directors' proposal, on an ordinary dividend of SEK 4.50 per share. The record date for receiving dividend was set to May 13, 2024, and thedividend is expected to be distributed on May 16, 2024. Tillkännagivande • Apr 19
Mycronic AB (publ) Provides Sales Guidance for the Full Year 2024 Mycronic AB (publ) provided sales guidance for the full year 2024. The Board of Directors' opinion remains that consolidated net sales for 2024 will be at a level of SEK 6.25 billion. Tillkännagivande • Apr 16
Mycronic AB (Publ) Launches Two New Products Mycronic AB (publ) launched two new products: The Prexision 8000 Evo, a next generation display mask writer that meets the highest performance requirements for display photomasks and the MMX, a cost-effective metrology system for measuring semiconductor photomasks. The Prexision 8 Evo is Mycronic's most advanced mask writer for displays to date. It improves the resolution by 10% compared to the Prexision 800 Evo, while maintaining writing speed. The price range for the Prexision 8000 Evo in a standard configuration is USD 40-45 million. The MMX is a new system for measuring the position of the written pattern, thereby ensuring the quality of the produced semiconductor photomask. The MMX is based on the SLX mask writer platform and Mycronic's existing Prexision-MMS metrology system for display photomasks. The price range for the MMX is USD 2-4 million and the total market is estimated to be two to four systems per year. Reported Earnings • Apr 05
Full year 2023 earnings released: EPS: kr10.22 (vs kr7.59 in FY 2022) Full year 2023 results: EPS: kr10.22 (up from kr7.59 in FY 2022). Revenue: kr5.71b (up 12% from FY 2022). Net income: kr998.0m (up 35% from FY 2022). Profit margin: 18% (up from 14% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 9.4% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has fallen by 4% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Tillkännagivande • Mar 21
Ivan Li Leaves Mycronic's Executive Management Mycronic AB (publ) announced as a result of the preparations ahead of a possible listing of Axxon on a stock exchange in China, effective March 19, 2024, Ivan Li leaves Mycronic's executive management but remains as Head of Axxon, the core of Mycronic´s High Volume division. The company has previously announced that the Board has decided to investigate the possibility of listing Axxon, the core of the High Volume division, on a stock exchange in China and floating a minority stake. Through this, Axxon would further strengthen its brand and market leadership position. By being more independent and having the means for fast expansion, the best possible conditions for Axxon are created to realize its success and full potential. However, the regulations stipulate that in such a situation, Ivan Li cannot be a member of Mycronic's executive management. Declared Dividend • Feb 19
Dividend of kr4.50 announced Shareholders will receive a dividend of kr4.50. Ex-date: 10th May 2024 Payment date: 16th May 2024 Dividend yield will be 15%, which is higher than the industry average of 1.4%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 1.3% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 32% over the next 2 years, which should provide support to the dividend and adequate earnings cover. Recent Insider Transactions • Feb 14
Chairman of the Board recently sold €3.9m worth of stock On the 9th of February, Patrik Tigerschiold sold around 135k shares on-market at roughly €28.95 per share. This transaction amounted to 57% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Patrik's only on-market trade for the last 12 months. New Risk • Feb 10
New major risk - Revenue and earnings growth Earnings have declined by 4.6% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. This is currently the only risk that has been identified for the company. Reported Earnings • Oct 23
Third quarter 2023 earnings released: EPS: kr2.10 (vs kr1.56 in 3Q 2022) Third quarter 2023 results: EPS: kr2.10 (up from kr1.56 in 3Q 2022). Revenue: kr1.27b (up 4.9% from 3Q 2022). Net income: kr205.0m (up 35% from 3Q 2022). Profit margin: 16% (up from 13% in 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Tillkännagivande • Oct 19
Mycronic AB (Publ) Provides Sales Guidance for the Year 2023 Mycronic AB (publ) provided sales guidance for the year 2023. The Board of Directors' opinion remains that net sales for 2023 will be at a level of SEK 5.5 billion. Tillkännagivande • Sep 21
Mycronic Appoints Nomination Committee The Nomination Committee for Mycronic’s 2024 Annual General Meeting has been appointed in accordance with the instructions for the Nomination Committee as decided by the 2023 Annual General Meeting. The Nomination Committee comprises: Henrik Blomquist, Bure Equity. Patrik Jönsson, SEB Funds. Thomas Ehlin, The Fourth Swedish National Pension Fund. Patrik Tigerschiöld, Chairman. Reported Earnings • Jul 14
Second quarter 2023 earnings released: EPS: kr1.37 (vs kr1.79 in 2Q 2022) Second quarter 2023 results: EPS: kr1.37 (down from kr1.79 in 2Q 2022). Revenue: kr1.25b (down 2.2% from 2Q 2022). Net income: kr134.0m (down 23% from 2Q 2022). Profit margin: 11% (down from 14% in 2Q 2022). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 3% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Tillkännagivande • Jul 14
Mycronic AB (Publ) Provides Sales Guidance for the Year 2023 Mycronic AB (publ) provided sales guidance for the year 2023. For the period, company expects net sales to be at a level of SEK 5.5 billion. Tillkännagivande • May 10
Mycronic AB (publ) Approves Ordinary Dividend, Payable on May 16, 2023 Mycronic AB (publ) at its Annual General Meeting held on May 9, 2023, approved an ordinary dividend of SEK 3.50 per share. The record date for receiving dividend was set to May 11, 2023, and the dividend is expected to be distributed on May 16, 2023. Upcoming Dividend • May 03
Upcoming dividend of kr3.50 per share at 1.7% yield Eligible shareholders must have bought the stock before 10 May 2023. Payment date: 16 May 2023. Payout ratio is a comfortable 47% and this is well supported by cash flows. Trailing yield: 1.7%. Lower than top quartile of German dividend payers (4.5%). Higher than average of industry peers (1.5%). Reported Earnings • Apr 08
Full year 2022 earnings released: EPS: kr7.59 (vs kr8.48 in FY 2021) Full year 2022 results: EPS: kr7.59 (down from kr8.48 in FY 2021). Revenue: kr5.12b (up 10% from FY 2021). Net income: kr741.0m (down 11% from FY 2021). Profit margin: 14% (down from 18% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 21% per year, which means it is well ahead of earnings. Reported Earnings • Feb 12
Full year 2022 earnings released: EPS: kr7.59 (vs kr8.48 in FY 2021) Full year 2022 results: EPS: kr7.59 (down from kr8.48 in FY 2021). Revenue: kr5.12b (up 10% from FY 2021). Net income: kr741.0m (down 11% from FY 2021). Profit margin: 14% (down from 18% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 1% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings. Reported Earnings • Oct 22
Third quarter 2022 earnings released: EPS: kr1.56 (vs kr0.82 in 3Q 2021) Third quarter 2022 results: EPS: kr1.56 (up from kr0.82 in 3Q 2021). Revenue: kr1.21b (up 23% from 3Q 2021). Net income: kr152.0m (up 90% from 3Q 2021). Profit margin: 13% (up from 8.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 3.1% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in Germany. Over the last 3 years on average, earnings per share has fallen by 2% per year whereas the company’s share price has fallen by 3% per year. Tillkännagivande • Oct 20
Mycronic AB (Publ) Provides Consolidated Net Sales Guidance for Year 2022 Mycronic AB (publ) provided consolidated net sales guidance for year 2022. It is the Board of Directors’ revised opinion that consolidated net sales for 2022 will be at a level of SEK 5 billion at prevailing exchange rates. Valuation Update With 7 Day Price Move • Oct 05
Investor sentiment improved over the past week After last week's 20% share price gain to €13.66, the stock trades at a forward P/E ratio of 21x. Average forward P/E is 15x in the Electronic industry in Germany. Total returns to shareholders of 27% over the past three years. Tillkännagivande • Sep 22
Mycronic AB (publ) Announces Retirement of Michael Chalsen as Senior Vice President Global Technologies and Member of Group Management Mycronic AB (publ) announced Michael Chalsen, Senior Vice President Global Technologies and member of it's Group Management, has decided to retire. He will stay on in his role until at least December 31, 2022. A recruitment process to find his successor has been initiated. Valuation Update With 7 Day Price Move • Sep 10
Investor sentiment improved over the past week After last week's 16% share price gain to €12.78, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 16x in the Electronic industry in Germany. Total returns to shareholders of 12% over the past three years. Reported Earnings • Jul 16
Second quarter 2022 earnings released: EPS: kr1.79 (vs kr1.84 in 2Q 2021) Second quarter 2022 results: EPS: kr1.79 (down from kr1.84 in 2Q 2021). Revenue: kr1.27b (up 20% from 2Q 2021). Net income: kr175.0m (down 2.8% from 2Q 2021). Profit margin: 14% (down from 17% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 8.8%, compared to a 20% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Tillkännagivande • Jul 14
Mycronic AB (Publ) Provides Earnings Guidance for the Year 2022 Mycronic AB (publ) provided earnings guidance for the year 2022. For the year, the company expects consolidated net sales for 2022 will be at a level of SEK 5 billion, based on exchange rates at the end of 2021. Upcoming Dividend • Apr 29
Upcoming dividend of kr3.00 per share Eligible shareholders must have bought the stock before 06 May 2022. Payment date: 12 May 2022. Payout ratio is a comfortable 49% and this is well supported by cash flows. Trailing yield: 1.8%. Lower than top quartile of German dividend payers (4.0%). Higher than average of industry peers (1.1%). Recent Insider Transactions • Apr 27
Independent Director recently bought €65k worth of stock On the 22nd of April, Staffan Dahlstrom bought around 4k shares on-market at roughly €16.14 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €280k more in shares than they have sold in the last 12 months. Tillkännagivande • Apr 21
Mycronic AB (Publ) Provides Sales Guidance for the Full Year 2022 Mycronic AB (publ) provides sales guidance for the full year 2022. The Board of Directors’ opinion that consolidated net sales for 2022 will be at a level of SEK 5 billion, based on exchange rates at the end of 2021. Reported Earnings • Apr 07
Full year 2021 earnings released: EPS: kr8.48 (vs kr7.10 in FY 2020) Full year 2021 results: EPS: kr8.48 (up from kr7.10 in FY 2020). Revenue: kr4.64b (up 19% from FY 2020). Net income: kr828.0m (up 19% from FY 2020). Profit margin: 18% (in line with FY 2020). Over the next year, revenue is forecast to grow 4.5%, compared to a 28% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 10% per year, which means it is well ahead of earnings. Tillkännagivande • Apr 05
Mycronic AB (publ) to Report Fiscal Year 2021 Final Results on Apr 04, 2022 Mycronic AB (publ) announced that they will report fiscal year 2021 final results on Apr 04, 2022 Recent Insider Transactions • Feb 13
Independent Director recently bought €53k worth of stock On the 11th of February, Robert Larsson bought around 3k shares on-market at roughly €17.71 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought €244k more in shares than they have sold in the last 12 months. Reported Earnings • Feb 10
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: kr8.48 (up from kr7.10 in FY 2020). Revenue: kr4.64b (up 19% from FY 2020). Net income: kr828.0m (up 19% from FY 2020). Profit margin: 18% (in line with FY 2020). Revenue exceeded analyst estimates by 2.9%. Over the next year, revenue is forecast to grow 9.9%, compared to a 23% growth forecast for the industry in Germany. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 14% per year, which means it is well ahead of earnings. Recent Insider Transactions • Nov 12
Independent Director recently bought €61k worth of stock On the 11th of November, Staffan Dahlstrom bought around 3k shares on-market at roughly €20.48 per share. In the last 3 months, there was an even bigger purchase from another insider worth €101k. Insiders have collectively bought €191k more in shares than they have sold in the last 12 months. Recent Insider Transactions • Oct 24
President & CEO recently bought €101k worth of stock On the 22nd of October, Anders Lindqvist bought around 5k shares on-market at roughly €19.80 per share. This was the largest purchase by an insider in the last 3 months. This was Anders' only on-market trade for the last 12 months. Reported Earnings • Oct 22
Third quarter 2021 earnings released The company reported a poor third quarter result with weaker earnings, revenues and profit margins. Third quarter 2021 results: Revenue: kr986.0m (down 7.7% from 3Q 2020). Net income: kr80.0m (down 70% from 3Q 2020). Profit margin: 8.1% (down from 25% in 3Q 2020). The decrease in margin was primarily driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 24% per year, which means it is well ahead of earnings. Tillkännagivande • Aug 19
Mycronic AB (publ) (OM:MYCR) agreed to acquire a 70% stake in Shenzhen Huan Cheng Xin Precision Manufacture Co., Ltd. Mycronic AB (publ) (OM:MYCR) agreed to acquire a 70% stake in Shenzhen Huan Cheng Xin Precision Manufacture Co., Ltd. on August 19, 2021. During 2020, Shenzhen Huan Cheng Xin Precision Manufacture Co., Ltd. generated sales of almost SEK 100 million. The remaining 30 percent can be acquired in 2025 in accordance with a predefined earnings multiple. The transaction is expected to be finalized in the fourth quarter of 2021. Reported Earnings • Jul 17
Second quarter 2021 earnings released: EPS kr1.84 (vs kr2.18 in 2Q 2020) The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2021 results: Revenue: kr1.06b (down 2.0% from 2Q 2020). Net income: kr180.0m (down 16% from 2Q 2020). Profit margin: 17% (down from 20% in 2Q 2020). The decrease in margin was primarily driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • Jul 15
Mycronic AB (Publ) Provides Consolidated Sales Guidance for the Year 2021 Mycronic AB (publ) provided consolidated sales guidance for the year 2021. For the year, the company expects consolidated net sales for 2021 will be at a level of SEK 4.5 billion,
based on prevailing exchange rates. Executive Departure • May 13
Employee Representative Director has left the company On the 6th of May, Johan Densjo's tenure as Employee Representative Director ended after 2.0 years in the role. We don't have any record of a personal shareholding under Johan's name. A total of 3 executives have left over the last 12 months. Tillkännagivande • May 06
Mycronic AB (publ) Approves Ordinary Dividend, Expected to Be Distributed on May 12, 2021 Mycronic AB (publ) at the Annual General Meeting resolved, in accordance with the Board of Directors' proposal, on an ordinary dividend of SEK 3.00 per share. The record date for receiving dividend was set to May 7, 2021, and the dividend is expected to be distributed on May 12, 2021. Upcoming Dividend • Apr 29
Upcoming dividend of kr3.00 per share Eligible shareholders must have bought the stock before 06 May 2021. Payment date: 12 May 2021. Trailing yield: 1.2%. Lower than top quartile of German dividend payers (3.2%). Higher than average of industry peers (0.8%). Tillkännagivande • Apr 24
Mycronic AB (publ) Provides Earnings Guidance for the Year 2021 Mycronic AB (publ) provided earnings guidance for the year 2021. The company board of directors' opinion that consolidated net sales for 2021 will be at a level of SEK 3.9 billion, based on 2020 closing exchange rates. Reported Earnings • Apr 11
Full year 2020 earnings released: EPS kr7.10 (vs kr8.73 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: kr3.88b (down 9.9% from FY 2019). Net income: kr694.0m (down 19% from FY 2019). Profit margin: 18% (down from 20% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 27% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Feb 27
New 90-day low: €20.46 The company is down 6.0% from its price of €21.74 on 27 November 2020. The German market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Electronic industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €17.76 per share. Tillkännagivande • Feb 26
Mycronic AB (publ) Receives Order for Two SLX Systems Mycronic AB (publ) has received an order for two SLX mask writers from an existing customer in the USA. The total order value is between USD 8 and 12 million. Delivery of the first SLX system is scheduled for the fourth quarter of 2021, while delivery of the second system is scheduled for the first half-year of 2022. Recent Insider Transactions • Feb 20
Chief Financial Officer recently bought €11k worth of stock On the 16th of February, Torbjörn Wingårdh bought around 500 shares on-market at roughly €22.61 per share. This was the largest purchase by an insider in the last 3 months. This was Torbjörn's only on-market trade for the last 12 months. Tillkännagivande • Feb 19
Aegis Software Announces That Mycronic Will Offer Aegis Software’S Factorylogix® Software Solution with Their K-Series 3D Aoi Equipment Platform Through an Extended Agreement Aegis Software announced that Mycronic will offer Aegis Software’s FactoryLogix® software solution with their K-Series 3D AOI (Automated Optical Inspection) equipment platform through an extended agreement between the two companies. For more than twenty years, Aegis Software and Mycronic have maintained a synergistic and mutually beneficial relationship, and this expansion offers exponential benefits to their respective customers. With this recent amendment, programming support is now enabled for the majority of Mycronic’s equipment, potentially enabling FactoryLogix to become a single-point programming tool for the entire MYPro assembly line. The powerful combination of Aegis Software and Mycronic AB are empowering manufacturers to accelerate New Product Introductions faster with less machine downtime, ultimately driving increased productivity and competitive advantage. FactoryLogix is a holistic and modular platform that delivers technology with easily configurable modules to support and execute a discrete manufacturer’s strategy towards Industry 4.0. FactoryLogix manages the entire manufacturing lifecycle: from product launch to material logistics, through manufacturing execution and quality management, to powerful analytics and real-time dashboards. Tillkännagivande • Feb 18
Mycronic Introduces New Range of High-Capacity MYTower Component Storage Systems Mycronic is introducing an expanded portfolio of intelligent component storage systems designed to enable higher capacity and greater flexibility. Two new models in the MYTower series of near-production storage systems include an innovative high-capacity platform enabling automated storage of up to one thousand component reels per square meter of floorspace. Mycronic's original SMD Tower, introduced more than a decade ago, pioneered a new category of space-efficient storage systems that streamlined inventory management and material handling. In the years since, more than 1,500 SMD Tower systems have been installed, forming the backbone of many manufacturers' increasingly automated and digitally integrated production systems. This previous product range, consisting of four SMD Tower models, will now be expanded with two new high-capacity models and an optional dual-terminal design to form the new MYTower series. The two newest MYTower models provide up to twice the storage capacity compared with their predecessors of the same height. The top-of-the-range MYTower 6X, for example, can store up to 2,468 7" diameter component reels within a footprint of just 1.95 square meters. A breakthrough in space efficiency, the MYTower 5X and 6X employ an innovative inventory system consisting of four rotating columns, each of which can contain five positions for 7" reels. An additional two positions can be used for 15" reel magazines or a versatile range of options for component trays and reels of other sizes. In addition to its significant capacity increase, the system offers all the same advantages as other MYTower and SMD Tower models, including the same retrieval times, automated recording of all stock movements and control and monitoring of MSD components, as well as safe component storage. All models in the series now also include an optional dual-terminal configuration that offers more flexible loading and unloading for multiple staff or robotics systems. The two terminals make it possible for one MYTower line to support dual access to storage for multiple pick-and-place lines, or to integrate robotic loading and unloading systems on one side while operators proceed uninterrupted on the other. The full range of MYTower systems, offering a flexible range of modular storage solutions for manufacturers of all sizes, is now available for order. Reported Earnings • Feb 11
Full year 2020 earnings released: EPS kr7.10 (vs kr8.73 in FY 2019) The company reported a poor full year result with weaker earnings, revenues and profit margins. Full year 2020 results: Revenue: kr3.88b (down 9.9% from FY 2019). Net income: kr694.0m (down 19% from FY 2019). Profit margin: 18% (down from 20% in FY 2019). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has fallen by 2% per year but the company’s share price has increased by 29% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Feb 11
Revenue misses expectations Revenue missed analyst estimates by 1.0%. Over the next year, revenue is forecast to grow 8.8%, compared to a 23% growth forecast for the Electronic industry in Germany. Tillkännagivande • Feb 11
Mycronic AB (publ), Annual General Meeting, May 05, 2021 Mycronic AB (publ), Annual General Meeting, May 05, 2021. Is New 90 Day High Low • Dec 30
New 90-day high: €24.38 The company is up 24% from its price of €19.74 on 01 October 2020. The German market is up 9.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €16.13 per share. Is New 90 Day High Low • Dec 10
New 90-day high: €22.70 The company is up 25% from its price of €18.19 on 11 September 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 8.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.13 per share. Tillkännagivande • Dec 05
Mycronic AB (publ) Receives Order for Two SLX Mask Writers Mycronic AB (publ) has received an order for SLX mask writers from an existing customer in the US. The order consists of two SLX mask writers and the total order value is between USD 12 million and USD 16 million. Delivery of the first system is planned for the first quarter of 2022, while delivery of the second system is planned for the third quarter of the same year. The SLX laser mask writer was launched at the end of October 2019 to meet rising demand for photomasks for the semiconductor industry, which is driven by long-term trends, and to meet the future need for replacement and modernization. Photomasks made by laser mask writers are very important in the manufacture of semiconductors and account for 70% to 75% of all photomasks produced. SLX is a new and modern mask writer based on the same technology as Micronics's mask writers for displays. Tillkännagivande • Nov 21
Mycronic AB Announces Strategic Partnership with Cogiscan Inc. to Provide Machine Connectivity for Industry 4.0 Applications Mycronic AB announced a new strategic partnership with Cogiscan Inc. to provide machine connectivity for Industry 4.0 applications. Mycronic's full range of SMT equipment and software, including printing, dispensing, placement, optical inspection and component storage solutions, combined with Cogiscan's multiprotocol connectivity platform, create a powerful offering of integrated machine and software systems for the printed circuit board assembly market. This partnership will enhance Mycronic's existing offering by providing plug-and-play machine communication solutions - using standard protocols such as CAMX, CFX and SECS/GEM, as well as tailored interfaces to leading proprietary and commercial MES's - to customers embarking on the journey for factory-wide connectivity and the Smart Factory. Electronics manufacturers who are looking to achieve full digitalization of their operations can expect to see a faster time-to-value and a more agile and more productive factory environment going forward. Is New 90 Day High Low • Nov 20
New 90-day high: €20.52 The company is up 28% from its price of €16.05 on 21 August 2020. The German market is up 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Electronic industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €14.11 per share. 
